search
Back to results

Comparing Silicone Hydrogel Contact Lens Wearers to Hydrogel Contact Lens Wearers and Non-lens Wearers

Primary Purpose

Myopia

Status
Active
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Daily Disposable Silicone Hydrogel Contact Lens
Daily Disposable Hydrogel Contact Lens
Non Lens Wearers
Sponsored by
Coopervision, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia

Eligibility Criteria

17 Years - 60 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Is between 17 and 60 years of age inclusive (age matching required between all 3 study groups), and has full legal capacity to volunteer;
  2. Has had a self-reported oculo-visual examination in the last two years.
  3. Has read and signed an information consent letter;
  4. Is willing and able to follow instructions and maintain the appointment schedule;
  5. No previous history of overnight contact lens wear or PMMA (polymethylmethacrylate) lens wear.
  6. Auto-refraction vertexed spherical equivalent between +4.00 and -8.00 (prescription matching required between groups 1 & 2). This criterion is non-applicable to participants in group 3.
  7. Is found to be in one of the study groups matched by age (±5 years), ethnicity (Asian vs. non-Asian) and CL Rx (±2.00 D) according using the following criteria.

    GROUP 1: For the past (minimum) 6 months has ONLY worn spherical DDSH lenses AND prior to wearing this lens they only wore SH material lenses in the past (minimum) 3 total years.

    GROUP 2: For the past (minimum) 6 months has ONLY worn spherical DDH lenses AND prior to wearing this lens they only wore H material lenses in the past (minimum) 3 total years.

  8. For groups 1 & 2, currently and for at least the previous 6 months has had habitual daily disposable wear schedule of at least 8 hrs a day, 5 days a week in only one material category - either silicone hydrogel or hydrogel material. This criterion is not-applicable to participants in group 3.
  9. Is willing to wear the study contact lens in the randomized eye for 3 hours of eye closure on the second study day. This criterion is not-applicable to participants in group 3.
  10. Has clear and healthy corneas and anterior eye and no active* ocular disease;
  11. Can achieve monocular HCVA of logMAR 0.10 or better in each eye with subjective refraction or pinhole.
  12. Can achieve acceptable fit and comfort in the randomized eye with the study lens. This criterion will be confirmed at the baseline visit (V1). This criterion is not-applicable to participants in group 3.
  13. Has a wearable pair of spectacles.

Exclusion Criteria:

  1. Is participating in any concurrent clinical trial;
  2. Is unable/unwilling to provide permission for the study site to seek CL history from their eye care practitioner
  3. Has any known active* ocular disease and/or infection;
  4. Has a systemic condition that in the opinion of the investigator may affect a study measure or interfere with contact lens wear; this may include, but not be limited to, diabetes, hyperthyroidism, recurrent herpes simplex/zoster, Sjogren's syndromes, xerophthalmia, acne rosacea, Stevens-Johnson syndromes, and systemic connective tissue disorders e.g. rheumatoid arthritis.
  5. Is using any systemic or topical medications that in the opinion of the investigator may affect a study measure;
  6. Has known sensitivity to fluorescein dye, topical anesthetic, or products to be used in the study;
  7. Appears to have any active* ocular pathology, ocular anomaly or severe insufficiency of lacrimal secretion (severe dry eye) that would affect the wearing of contact lenses;
  8. Appears to have any signs of corneal inflammation or previous infection or corneal opacity/scar;
  9. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit), due to potential ocular physiological changes, such as changes in the corneal shape and cell types;
  10. Is aphakic;
  11. Has undergone refractive error surgery, or has a history of any ocular surgery or injury.
  12. Is a toric or multifocal contact lens wearer.

Sites / Locations

  • Eurolens Research

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Daily Disposable Silicone Hydrogel Contact Lens

Habitual Daily Disposable Hydrogel Contact Lens

Non-lens wearers

Arm Description

Subjects will be randomized to wear Daily Disposable Silicone Hydrogel Contact Lens in one eye and will be patched for 3 hours with the contralateral eye remain open.

Subjects will be randomized to wear Daily Disposable Hydrogel Contact Lens in one eye and will be patched for 3 hours with the contralateral eye remain open.

Subjects with no previous history of contact lens wear

Outcomes

Primary Outcome Measures

Limbal Redness
Limbal redness will be measured on EFRON Scale of 0-4, 0.1 steps (0-none, 1- Trace, 2-Mild, 3-Moderate, 4- Severe)
Bulbar Redness
Bulbar redness will be measured on EFRON Scale of 0-4, 0.1 steps (0-none, 1- Trace, 2-Mild, 3-Moderate, 4- Severe)
Corneal vessel ingrowth
Corneal vessel ingrowth will be measured using slit lamp photography and image analysis for longest vessel in mm (0.1 to 5mm in 0.01 steps, 0.1mm - Short Vessel, 5mm - Long vessel)
Number of Corneal vessel ingrowth
Number of Corneal vessel ingrowth greater than 0.5mm will be measured using slit lamp photography and image analysis on a scale of 0-99 (0- best, 99- worst case)

Secondary Outcome Measures

Full Information

First Posted
May 10, 2021
Last Updated
March 5, 2022
Sponsor
Coopervision, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04886479
Brief Title
Comparing Silicone Hydrogel Contact Lens Wearers to Hydrogel Contact Lens Wearers and Non-lens Wearers
Official Title
Comparing Habitual Daily Disposable Silicone Hydrogel Contact Lens Wearers to Habitual Daily Disposable Hydrogel Contact Lens Wearers and Non-lens Wearers
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 30, 2021 (Actual)
Primary Completion Date
August 31, 2022 (Anticipated)
Study Completion Date
October 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coopervision, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary objectives of this study is to to compare baseline data between 3 groups - habitual wearers of DDSH (Daily Disposable Silicone Hydrogel) contact lenses / habitual wearers of DDH (Daily Disposable Hydrogel) contact lenses / non-lens wearers for physiological responses and to compare the physiological responses post closed eye lens wear in 2 groups - habitual wearers of DDSH /habitual wearers of DDH after 3 hours.
Detailed Description
This study is a multi-site, prospective, randomized, non-masked, unilateral, non-dispensing study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
78 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Daily Disposable Silicone Hydrogel Contact Lens
Arm Type
Experimental
Arm Description
Subjects will be randomized to wear Daily Disposable Silicone Hydrogel Contact Lens in one eye and will be patched for 3 hours with the contralateral eye remain open.
Arm Title
Habitual Daily Disposable Hydrogel Contact Lens
Arm Type
Active Comparator
Arm Description
Subjects will be randomized to wear Daily Disposable Hydrogel Contact Lens in one eye and will be patched for 3 hours with the contralateral eye remain open.
Arm Title
Non-lens wearers
Arm Type
Active Comparator
Arm Description
Subjects with no previous history of contact lens wear
Intervention Type
Device
Intervention Name(s)
Daily Disposable Silicone Hydrogel Contact Lens
Intervention Description
Subjects will be randomized to wear Daily Disposable Silicone Hydrogel Contact Lens in one eye and will be patched for 3 hours with the contralateral eye remain open.
Intervention Type
Device
Intervention Name(s)
Daily Disposable Hydrogel Contact Lens
Intervention Description
Subjects will be randomized to wear Daily Disposable Hydrogel Contact Lens in one eye and will be patched for 3 hours with the contralateral eye remain open.
Intervention Type
Other
Intervention Name(s)
Non Lens Wearers
Intervention Description
Subjects with no previous history of contact lens wear
Primary Outcome Measure Information:
Title
Limbal Redness
Description
Limbal redness will be measured on EFRON Scale of 0-4, 0.1 steps (0-none, 1- Trace, 2-Mild, 3-Moderate, 4- Severe)
Time Frame
3 hours
Title
Bulbar Redness
Description
Bulbar redness will be measured on EFRON Scale of 0-4, 0.1 steps (0-none, 1- Trace, 2-Mild, 3-Moderate, 4- Severe)
Time Frame
3 hours
Title
Corneal vessel ingrowth
Description
Corneal vessel ingrowth will be measured using slit lamp photography and image analysis for longest vessel in mm (0.1 to 5mm in 0.01 steps, 0.1mm - Short Vessel, 5mm - Long vessel)
Time Frame
3 hours
Title
Number of Corneal vessel ingrowth
Description
Number of Corneal vessel ingrowth greater than 0.5mm will be measured using slit lamp photography and image analysis on a scale of 0-99 (0- best, 99- worst case)
Time Frame
3 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
17 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Is between 17 and 60 years of age inclusive (age matching required between all 3 study groups), and has full legal capacity to volunteer; Has had a self-reported oculo-visual examination in the last two years. Has read and signed an information consent letter; Is willing and able to follow instructions and maintain the appointment schedule; No previous history of overnight contact lens wear or PMMA (polymethylmethacrylate) lens wear. Auto-refraction vertexed spherical equivalent between +4.00 and -8.00 (prescription matching required between groups 1 & 2). This criterion is non-applicable to participants in group 3. Is found to be in one of the study groups matched by age (±5 years), ethnicity (Asian vs. non-Asian) and CL Rx (±2.00 D) according using the following criteria. GROUP 1: For the past (minimum) 6 months has ONLY worn spherical DDSH lenses AND prior to wearing this lens they only wore SH material lenses in the past (minimum) 3 total years. GROUP 2: For the past (minimum) 6 months has ONLY worn spherical DDH lenses AND prior to wearing this lens they only wore H material lenses in the past (minimum) 3 total years. For groups 1 & 2, currently and for at least the previous 6 months has had habitual daily disposable wear schedule of at least 8 hrs a day, 5 days a week in only one material category - either silicone hydrogel or hydrogel material. This criterion is not-applicable to participants in group 3. Is willing to wear the study contact lens in the randomized eye for 3 hours of eye closure on the second study day. This criterion is not-applicable to participants in group 3. Has clear and healthy corneas and anterior eye and no active* ocular disease; Can achieve monocular HCVA of logMAR 0.10 or better in each eye with subjective refraction or pinhole. Can achieve acceptable fit and comfort in the randomized eye with the study lens. This criterion will be confirmed at the baseline visit (V1). This criterion is not-applicable to participants in group 3. Has a wearable pair of spectacles. Exclusion Criteria: Is participating in any concurrent clinical trial; Is unable/unwilling to provide permission for the study site to seek CL history from their eye care practitioner Has any known active* ocular disease and/or infection; Has a systemic condition that in the opinion of the investigator may affect a study measure or interfere with contact lens wear; this may include, but not be limited to, diabetes, hyperthyroidism, recurrent herpes simplex/zoster, Sjogren's syndromes, xerophthalmia, acne rosacea, Stevens-Johnson syndromes, and systemic connective tissue disorders e.g. rheumatoid arthritis. Is using any systemic or topical medications that in the opinion of the investigator may affect a study measure; Has known sensitivity to fluorescein dye, topical anesthetic, or products to be used in the study; Appears to have any active* ocular pathology, ocular anomaly or severe insufficiency of lacrimal secretion (severe dry eye) that would affect the wearing of contact lenses; Appears to have any signs of corneal inflammation or previous infection or corneal opacity/scar; Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit), due to potential ocular physiological changes, such as changes in the corneal shape and cell types; Is aphakic; Has undergone refractive error surgery, or has a history of any ocular surgery or injury. Is a toric or multifocal contact lens wearer.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lyndon Jones, PhD FCOptom
Organizational Affiliation
Centre for Ocular Research & Education
Official's Role
Principal Investigator
Facility Information:
Facility Name
Eurolens Research
City
Manchester
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Comparing Silicone Hydrogel Contact Lens Wearers to Hydrogel Contact Lens Wearers and Non-lens Wearers

We'll reach out to this number within 24 hrs